DexCom IncStockStory highlights DexCom as a top Nasdaq 100 pick, citing strong organic revenue growth and expanding free cash flow margin.
StockStory identified Rocket Lab, Intuitive Surgical, and DexCom as three Nasdaq 100 stocks with promising prospects. Rocket Lab, with a market cap of $66.44 billion, achieved annual revenue growth of 55.1% over the past two years and improved its operating margin by 111.4 percentage points over five years. Intuitive Surgical, valued at $146.2 billion, posted annual revenue growth of 20.2% over the last two years and annual earnings per share growth of 21.3% over five years, supported by share repurchases. DexCom, with a market cap of $29.04 billion, recorded organic revenue growth averaging 12.5% over the past two years and expanded its free cash flow margin by 26 percentage points over five years.
DexCom IncStockStory highlights DexCom as a top Nasdaq 100 pick, citing strong organic revenue growth and expanding free cash flow margin.
Intuitive Surgical IncStockStory highlights Intuitive Surgical as a top Nasdaq 100 pick, noting revenue and earnings growth supported by share repurchases.
Rocket Lab USA Inc.StockStory highlights Rocket Lab as a top Nasdaq 100 pick, citing strong revenue growth and operating margin improvement.